BioCryst Pharmaceuticals
BCRX
#4770
Rank
$1.57 B
Marketcap
$7.60
Share price
1.47%
Change (1 day)
37.68%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2024 (TTM): -$0.15 Billion USD

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are $0.38 Billion USD. In 2023 the company made an earning of -$0.23 Billion USD, an increase over its 2022 earnings that were of -$0.25 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -$0.15 Billion-35.24%
2023 -$0.23 Billion-7.43%
2022 -$0.25 Billion34.42%
2021 -$0.19 Billion-0.55%
2020 -$0.19 Billion67.88%
2019 -$0.11 Billion7.55%
2018 -$0.11 Billion53.92%
2017 -$65.79 Million19.29%
2016 -$55.15 Million28.19%
2015 -$43.02 Million-4.8%
2014 -$45.19 Million50.09%
2013 -$30.11 Million-23.29%
2012 -$39.25 Million-26.19%
2011 -$53.18 Million54.78%
2010 -$34.36 Million150.1%
2009 -$13.74 Million-49.43%
2008 -$27.17 Million14.07%
2007 -$23.82 Million-49.31%
2006 -$46.98 Million72.87%
2005 -$27.18 Million22.08%
2004 -$22.27 Million75.3%
2003 -$12.7 Million-25.36%
2002 -$17.02 Million225.05%
2001 -$5.24 Million-56.6%
2000 -$12.07 Million50.63%
1999 -$8.01 Million38.05%
1998 -$5.8 Million-52.46%
1997 -$12.2 Million58.44%
1996 -$7.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$21.45 M-114.65%๐Ÿ‡บ๐Ÿ‡ธ USA
$62.22 M-142.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-$8.3 Million-94.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.28 Billion 86.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.53 B-1,149.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.17 Billion 11.46%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.17 B-2,947.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$0.49 Billion 233.66%๐Ÿ‡บ๐Ÿ‡ธ USA
-$27.69 Million-81.10%๐Ÿ‡บ๐Ÿ‡ธ USA